Epigenetic downregulation of desmin in gall bladder cancer reveals its potential role in disease progression

BACKGROUND & OBJECTIVES: Gall bladder cancer (GBC) is a fatal neoplasm, with a globally variable incidence rates. To improve the survival rate of patients, a newer set of biomarkers needs to be discovered for its early detection and better prognosis. Our earlier studies on GBC proteomics and who...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhunia, Shushruta, Barbhuiya, Mustafa Ahmed, Gupta, Sanjiv, Shrivastava, Braj Raj, Tiwari, Pramod Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371065/
https://www.ncbi.nlm.nih.gov/pubmed/32461394
http://dx.doi.org/10.4103/ijmr.IJMR_501_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371065/
https://www.ncbi.nlm.nih.gov/pubmed/32461394
http://dx.doi.org/10.4103/ijmr.IJMR_501_18

Ejemplares similares